EN / JP

Top＞News Lists
News Lists
2026.04.20
JPH034 Phase I Clinical Trial Registered on ClinicalTrials.gov
2026.04.13
Notice of Availability of Webinar Recording Hosted by the Cholangiocarcinoma Foundation – Advancing Understanding of the Global Phase 3 Clinical Trial of Nanvuranlat –
2026.04.01
Notice of Webinar Hosted by the Cholangiocarcinoma Foundation – Advancing Understanding of the Global Phase 3 Clinical Trial of Nanvuranlat –
2026.03.25
Notice of Listing on the Tokyo Stock Exchange Growth Market
2026.03.23
J-Pharma Initiates Phase I Clinical Trial of JPH034 – First Subject Dosed
2026.02.19
Notice of Approval for Listing on the Tokyo Stock Exchange Growth Market
2026.02.16
The IND Safety Review for JPH034 Has Been Completed, Advancing Toward Initiation of a Phase 1 Clinical Trial in the United States
2025.12.19
Nanvuranlat Beacon-BTC Global Phase III Clinical Trial Commences with First Site Activation
2025.12.08
Nanvuranlat Registered on the U.S. Database ClinicalTrials.gov ~In Advance of the Initiation of the Global Phase III Clinical Trial~
2025.10.19
2025 European Society for Medical Oncology (ESMO) Annual Congress: Presentation of Subgroup Analysis Results from the Phase II Clinical Trial of Nanvuranlat Suggesting Patient Selection Criteria for the Global Phase III Clinical Trial
1 2 3 4 5 6 7 8